The author critiques Dr. Linda van Paaschen’s dismissive attitude towards ADHD diagnoses and medication, arguing that her flippant characterization trivializes the struggles of those with the condition. Van Paaschen suggests that an ADHD diagnosis is easily obtained simply by exhibiting common traits like being uncertain or unsure of one’s identity, further implying that the readily available medication is a form of freely accessible stimulant. This perspective, the author contends, ignores the rigorous diagnostic process and the significant challenges, particularly for girls, in receiving an accurate and timely diagnosis, let alone adequate treatment. Experts emphasize the extensive difficulties girls face in obtaining an ADHD diagnosis, and even when diagnosed, they are often denied effective medical and psychosocial interventions.
The author challenges van Paaschen’s comparison of ADHD medication to freely available narcotics, highlighting the crucial distinction between responsible medical prescription and the dangers of unregulated substance use. While acknowledging that ADHD medication, like morphine, is a controlled substance due to its chemical composition, the author emphasizes the crucial role both medications play in alleviating suffering. The author draws a parallel to the opioid crisis, cautioning against irresponsible prescription practices while simultaneously defending the legitimate medical applications of these drugs when prescribed judiciously and monitored carefully. This argument underscores the importance of distinguishing between the responsible use of controlled substances in a medical context and their potential for abuse when unregulated.
The article then broadens its scope to address the societal stigma surrounding medication for conditions perceived as ”natural” or character flaws. The author observes a tendency to dismiss certain struggles as inherent aspects of life that individuals should simply endure, rather than actively seek treatment and relief. This societal pressure, the author argues, perpetuates unnecessary suffering and reinforces negative attitudes towards seeking help for mental and emotional distress. It highlights a societal bias towards enduring discomfort rather than seeking medical intervention. This bias, the author posits, often stems from a misunderstanding of the severity and debilitating nature of these conditions.
This societal stigma is further exemplified by the historical treatment of antidepressants. Often derided as “happy pills,” antidepressants have long been perceived as a frivolous solution for those unable to cope with normal life challenges, thereby minimizing the profound impact of depression. The author points to the significant decrease in suicide rates since the introduction of SSRI antidepressants, emphasizing their crucial role in treating severe depression and saving lives. Despite this positive impact, criticism persists, perpetuating the notion that these medications are unnecessary crutches for those unwilling to confront life’s inherent ups and downs. This, the author argues, perpetuates a dangerous narrative that discourages individuals from seeking necessary treatment.
Similarly, ADHD medication has been targeted due to its classification as a controlled substance, even though untreated ADHD significantly increases the risk of substance abuse. The author finds this ironic, given that proper medication can mitigate the very risks used to argue against its use. Until recently, individuals with both ADHD and addiction faced the paradoxical situation of being denied the very medication that could help them manage their condition and avoid further substance abuse. This highlights the complex interplay between stigma, misunderstanding, and access to appropriate care. The author argues that such policies demonstrate a fundamental lack of understanding of the complexities of ADHD and its potential comorbidities.
The author concludes by emphasizing the spectrum nature of mental and neuropsychiatric conditions. While everyone experiences variations in mood, energy, and focus, the distinction lies in the severity, duration, and impact on daily functioning. What might be addressed by lifestyle changes in a neurotypical individual can be a debilitating struggle for someone with a clinical diagnosis. The author uses the analogy of a long walk and a good night’s sleep being sufficient for a neurotypical person to recover from a low mood, while someone with clinical depression requires more intensive intervention. This analogy highlights the crucial difference between experiencing common emotional fluctuations and suffering from a clinical condition requiring professional treatment. This lack of understanding, the author suggests, leads to harmful oversimplifications like the ”just get over it” mentality. The author extends this analogy to weight management, noting the similar societal pressure to ”just eat less and exercise more,” despite overwhelming evidence that this is rarely an effective long-term solution for severe obesity. Even with the advent of effective weight-loss medications, criticism and moral judgment persist, targeting individuals for seeking medical assistance rather than relying solely on willpower.
The author’s overarching argument calls for greater empathy and understanding of the diverse ways individuals experience and manage their mental and physical health. Criticizing those who seek medical intervention for conditions perceived as “natural” reflects a flawed understanding of the complexities of human biology and the spectrum nature of health and illness. The author champions the advancements of modern medicine that offer relief from debilitating conditions, urging readers to embrace a more compassionate and informed perspective on healthcare choices. Just as it is natural to experience sadness or fluctuations in weight, it is also natural to succumb to illness. Modern medicine, the author emphasizes, offers a vital reprieve from such natural but often harmful processes, providing individuals with the tools and support to live healthier and more fulfilling lives. The author concludes by highlighting the inherent value of medical advancements in mitigating suffering and improving the quality of life for those struggling with conditions often dismissed or misunderstood.
